Mexico's controversial vending machines for essential medications spark legal and health concerns

Mexico's controversial vending machines for essential medications spark legal and health concerns

John Bailey
John Bailey•
• 2 Min.
"Medicine vending machines don't solve shortages"

Mexico's controversial vending machines for essential medications spark legal and health concerns

Mexico’s Health Ministry has announced plans to install vending machines dispensing 22 essential medications. The initiative targets chronic conditions like diabetes, hypertension, and kidney disease, which commonly affect older adults. However, critics argue the scheme fails to tackle deeper issues in the country’s pharmaceutical supply chain. Health Secretary David Kershenobich stated that the selected medications were chosen to meet the needs of elderly patients. The list includes treatments for widespread conditions, aiming to improve access in government-run health centres.

Undersecretary Eduardo Clark confirmed the machines would be placed in health facilities but provided no specifics on numbers, costs, or restocking schedules. He also did not clarify how prescriptions would be verified or how storage conditions would be maintained. Legal concerns have been raised over the plan. Article 226 of Mexico’s General Health Law bans medication distribution from mobile or temporary units unless prescriptions are properly logged. Article 259 further requires a qualified professional to oversee product safety and pharmacovigilance at all dispensing points. Experts have criticised the initiative as poorly planned. Health policy analyst Xavier Tello called it 'absurd', questioning its legal basis and practicality. Public health specialist Adriana Rocha warned that digital illiteracy could exclude some patients and that automated dispensing might compromise treatment safety. Both argued that the scheme does nothing to resolve Mexico’s ongoing drug shortages, which remain the core issue in public health centres.

The vending machine proposal aims to streamline medication access for chronic illnesses. Yet, without addressing supply shortages or clarifying legal and logistical details, its effectiveness remains uncertain. Critics stress that deeper reforms are needed to ensure reliable drug availability across the country.

Neueste Nachrichten